Skip to content
Tech News
clear
Topics: Today This Week This Month This Year

MIT Tech Review examines AI's role in enabling bioweapon design

MIT Technology Review's newsletters explore how AI tools could be misused to create bioweapons, citing a 2022 study where an AI drug-discovery model generated 40,000 potentially toxic molecules in under six hours. The coverage also notes that advances in gene editing and synthetic biology have made biotech more accessible, even as safeguards remain imperfect.

Treble secures $18M to expand voice AI simulation and testing platform

Iceland-based Treble, founded in 2020 by acoustic engineers Finnur Pind and Jesper Pedersen, has closed an $18 million extension to its Series A round led by Paladin Capital Group, with backing from KOMPAS VC, Frumtak Ventures, EIC, and Omega ehf. The funding brings Treble's total raised to over $40 million, following a $12 million round in 2024, and the company already counts Amazon and Logitech among its customers.

Datamimic Community Edition offers open-source engine for synthetic test data

Datamimic has released a Community Edition of its data engine as an open-source, MIT-licensed, Python-native tool that generates deterministic synthetic datasets and pseudonymizes PII in staging or QA exports. The CE version runs standalone across databases and file formats like PostgreSQL, MongoDB, CSV and JSON, while a paid Enterprise Platform adds governed workflows, PII scanning, access controls, audit logging and scheduling for regulated industries.

Research review maps limits of enzymes in breaking down plastics like PET

A compiled body of scientific literature examines how microbial and engineered enzymes degrade synthetic polymers, with much of the progress concentrated on PET plastics through hydrolase and cutinase-based approaches. The references trace advances from early enzymatic surface modification studies to more recent engineered PET depolymerases capable of breaking down and recycling plastic bottles at scale.

Colossal Biosciences CEO to discuss AI-driven de-extinction at TechCrunch Disrupt 2026

TechCrunch Disrupt 2026, running October 13-15 in San Francisco, will host a fireside chat titled 'Can We Engineer Nature's Comeback?' featuring Ben Lamm, co-founder and CEO of Colossal Biosciences. The session will examine how AI and synthetic biology are being used to attempt reviving extinct species and what that means for conservation efforts.

Study finds AI research agents still lack creativity for independent scientific work

A new evaluation of AI research agents, described by researcher Sayash Kapoor, found the systems performed strong engineering tasks but produced papers far below top AI conference standards. The agents ran flawed experiments, struggled to explain their findings clearly, abandoned promising hypotheses too early, and failed to meaningfully use feedback, time, or compute resources.

ESA to build Envision Venus orbiter solo after NASA drops radar contribution

The European Space Agency is pressing ahead with its Envision mission to Venus after NASA signaled it likely can't deliver the US-built synthetic aperture radar it had promised under a 2024 partnership agreement. That radar was meant to be the spacecraft's main tool for mapping the planet's volcanic surface through its thick sulfuric-acid clouds at ten times the resolution of NASA's 1990s Magellan mission. ESA's project scientist says development will continue at full pace regardless.

b.next scales open-source PURE system into Cytosol synthetic cell kits, ships 100th unit

Academic group b.next set out in 2023 to build a simple open-source synthetic cell sensor using fully specified components, aiming to make an accessible version of the PURE protein synthesis system. That effort snowballed into building actual manufacturing infrastructure, and the team now runs a plant producing 'Cytosol,' a core material for constructing synthetic cells based on open Nucleus specifications, having recently shipped its 100th kit.

b.next scales open-source PURE system into Cytosol manufacturing after shipping 100th kit

b.next, originally an academic effort focused on synthetic cell interoperability through its Nucleus platform, took on a 2023 contract to build an open, fully specified synthetic cell sensor. That project, intended to take months, evolved into years of work solving supply chain gaps for PURE system components, ultimately leading the team to build a manufacturing plant producing 'Cytosol,' a core substrate for synthetic cells, and recently shipping its 100th kit.

Researchers build self-assembling protein nanoparticles to deliver RNA into cells

Scientists engineered synthetic protein assemblies from the bottom up that can package and transport RNA molecules into human cells, using standard molecular cloning and transfection techniques in HEK293T cell lines. They validated the approach with a split-luciferase reporter system to confirm successful RNA delivery and functional expression inside cells.

AI Deepfakes of Politicians Raise Alarms Ahead of 2026 Midterms

Generative AI tools from companies like OpenAI, Google and Meta have made it far easier to produce convincing fake audio, video and images of public figures, fueling a rise in political deepfakes. Doppel's Bobby Ford describes the trend as driven by three factors: greater volume, faster velocity and more vectors such as video, audio and email being exploited by bad actors. The piece cites the 2024 New Hampshire robocall incident, where an AI-generated fake of Joe Biden's voice urged voters to stay home, as an early warning sign for what could happen in the 2026 midterms.

Today's top topics: openai samsung smart glasses android authority gemini adobe premiere anthropic data centers galaxy s27 ultra battersea power station
View all today's topics →